|国家科技期刊平台
| 注册
首页|期刊导航|癌症生物学与医学（英文版）|Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma

Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma

Yi Wang Wenjie Xiong Huimin Liu Qi Sun Huijun Wang Zhijian Xiao Jianxiang Wang Lugui Qiu Dehui Zou Shuhua Yi Yuting Yan Dandan Shan Jiawen Chen Wei Liu Tingyu Wang Gang An Weiwei Sui Wenyang Huang

癌症生物学与医学（英文版）2025，Vol.22Issue(2)：177-189,13.
✕
癌症生物学与医学（英文版）2025，Vol.22Issue(2)：177-189,13.DOI:10.20892/j.issn.2095-3941.2024.0200

Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma

Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma

Yi Wang 1Wenjie Xiong 1Huimin Liu 1Qi Sun 1Huijun Wang 1Zhijian Xiao 1Jianxiang Wang 1Lugui Qiu 1Dehui Zou 1Shuhua Yi 1Yuting Yan 1Dandan Shan 1Jiawen Chen 1Wei Liu 1Tingyu Wang 1Gang An 1Weiwei Sui 1Wenyang Huang1

作者信息

  • 1. State Key Laboratory of Experimental Hematology,National Clinical Research Center for Blood Diseases,Haihe Laboratory of Cell Ecosystem,Institute of Hematology&Blood Diseases Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Tianjin 300020,China||Tianjin Institutes of Health Science,Tianjin 301600,China
  • 折叠

摘要

关键词

Mantle cell lymphoma/immunochemotherapy/high-risk factors/minimal residual disease/adverse events

Key words

Mantle cell lymphoma/immunochemotherapy/high-risk factors/minimal residual disease/adverse events

引用本文复制引用

Yi Wang,Wenjie Xiong,Huimin Liu,Qi Sun,Huijun Wang,Zhijian Xiao,Jianxiang Wang,Lugui Qiu,Dehui Zou,Shuhua Yi,Yuting Yan,Dandan Shan,Jiawen Chen,Wei Liu,Tingyu Wang,Gang An,Weiwei Sui,Wenyang Huang..Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma[J].癌症生物学与医学（英文版）,2025,22(2):177-189,13.

基金项目

This study was supported by grants from the National Natural Science Foundation of China(Grant Nos.82200215,82170193,and 82370197)and the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences(Grant No.2022-I2M-1-002). （Grant Nos.82200215,82170193,and 82370197）

癌症生物学与医学（英文版）

2095-3941

访问量0
|
下载量0
段落导航相关论文